{
    "Case ID": "010200",
    "Crime_Name": [
        "Patent Infringement"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent validity and infringement"
    ],
    "Legal_Issue": [
        "Whether manufacturing and selling citalopram infringes Lundbeck's '368 patent"
    ],
    "Governing_Law": [
        "PM (NOC) Regulations"
    ],
    "Procedural_Stage": [
        "Application to prohibit Notice of Compliance"
    ],
    "Evidence_Assessment": [
        "Expert evidence showed citalopram treats depression but lacks substantial proof for dementia or CVD treatment"
    ],
    "Decision_Outcome": [
        "Court dismissed Lundbeck's application"
    ],
    "Burden_of_Proof": [
        "Generic manufacturer must prove non-infringement"
    ],
    "Credibility_Factor": [
        "Genpharm's intent to market only for depression"
    ],
    "Legal_Rule": [
        "Under PM (NOC) Regulations, a generic manufacturer must prove non-infringement of listed patents"
    ],
    "Standard_of_Review": [
        "Justification based on evidence"
    ],
    "Procedural_Issue": [
        "Application under PM (NOC) Regulations to block marketing approval"
    ],
    "Grounds_for_Claim": [
        "Lundbeck alleged potential use of citalopram for patented indications (dementia, CVD)"
    ],
    "Outcome_on_Merits": [
        "Genpharm's allegation of non-infringement was justified"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Application dismissed"
    ],
    "Review_Standard": [
        "Evaluation of whether allegations are evidence-based"
    ],
    "Procedural_Fairness_Assessment": [
        "Genpharm had opportunity to present evidence of intended use"
    ],
    "Key_Evidence_Considered": [
        "Expert testimony on therapeutic uses of citalopram",
        "Genpharm's labeling and intended use"
    ],
    "Legal_Framework": [
        "Regulatory framework for drug approval and patent linkage under PM (NOC) Regulations"
    ],
    "Applicant_Challenge": [
        "Genpharm challenged the enforceability of Lundbeck's patent in relation to its product"
    ],
    "Court_Result": [
        "Allowed Genpharm to proceed without proving non-infringement definitively"
    ],
    "Legal_Rule_Source": [
        "PM (NOC) Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Genpharm claimed its product is indicated solely for depression, not for dementia or CVD"
    ],
    "Evidence_Type": [
        "Expert evidence",
        "Product labeling",
        "Scientific literature"
    ],
    "Remedy_Requested": [
        "Lundbeck requested prohibition of Notice of Compliance"
    ],
    "Outcome": [
        "Request denied; Genpharm permitted to obtain Notice of Compliance"
    ],
    "Decision_Authority": [
        "Federal Court"
    ],
    "Remedy_Sought": [
        "Interim injunction to prevent market entry until patent expiry"
    ],
    "Resolution_Mechanism": [
        "Judicial determination under PM (NOC) Regulations"
    ],
    "Legal_Provision": [
        "Section of PM (NOC) Regulations regarding patent listing and certification"
    ],
    "Authority": [
        "Health Canada",
        "Courts"
    ],
    "Claimant_Status": [
        "Patent holder (Lundbeck)"
    ],
    "Legal_Provision_Cited": [
        "PM (NOC) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of potential off-label use not sufficient to prove infringement"
    ],
    "Applicable_Process": [
        "Notice of Compliance (NOC) proceeding"
    ],
    "Outcome_of_Review": [
        "No prohibition issued"
    ],
    "Pending_Relief_or_Application": [
        "Application to prohibit issuance of NOC"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "PM (NOC) Regulations"
    ]
}